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Nowadays, our understanding of gastric cancer has been improved. The major hope is to increase the
survival rates of this aggressive, enigmatic and heterogeneous disease, especially in Western population.
Over the past decades, conventional surgery has been the cornerstone of treatment for non metastatic
gastric cancer patients. Adequate gastrectomy is recommended for at least T2e4a tumors, while T4b
tumors require resection of involved structures. However, in the era of advanced technology, minimally
invasive surgical approaches are in the top of the scientiﬁc interest. Notably, the laparoscopic approach
for gastric cancer is a topic that remain controversial. In this review, we summarize the standard of care
according to the current evidences and we provide the latest scientiﬁc information assessing safety and
efﬁcacy of laparoscopic gastrectomy for gastric cancer.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Although the incidence of gastric cancer has been decreased
over the past decades, and although the oncologic treatment of
gastric cancer has dramatically changed during the last years,
mainly due to the advances of chemotherapy, it continues to be a
major health problem. Gastric cancer is the fourth most common
malignancy and the second cause of death among all cancers [1,2].
There is no doubt that it is an aggressive disease with poor prog-
nosis, that accounts for 800.000e1.000.000 cancer deaths eachoannina University Hospital,
search Center, Insubria Uni-
os).
by Elsevier Ltd. All rights reservedyear [2,3]. Its prevalence shows wide variability throughout the
world. South Korea and Japan are reported to have the highest
incidence as well. In China, gastric carcinoma is one of the most
common malignant tumors, while Europe and America are
considered regions with intermediate incidence. Recent evidences
estimate that the 5-year survival rate of gastric cancer in Western
countries is 40%, with a median survival time of about 24 months
[4]. Interestingly, the 5-year survival rate in Eastern countries is
approximately 52%, which is attributed to earlier disease diagnosis
after screening programs and more aggressive surgical treatment
[5].
It is widely accepted that radical surgery is the cornerstone of
therapy in gastric cancer patients; this entails an appropriate gas-
trectomy with an adequate lymph node dissection. Although nodal
status is one of the most critical independent predictors of patient
survival after gastrectomy, the extent of lymph node dissection is.
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phadenectomy in patients with gastric cancer is the gold standard
of care from many years, while many Western surgeons nowadays
still perform a limited (D1) lymphadenectomy for gastric cancer [7].
Notably, in Western countries and in USA, D2 lymphadenectomy
only recently became a recommended surgical option, speciﬁcally
after the simpliﬁcation of nodal dissection by the latest Japanese
guidelines [7e9]. Over the past years, open surgery has been the
standard treatment with much more different comparisons be-
tween East and West in terms of survival.
However, in the era of minimally invasive techniques, laparo-
scopic gastrectomy represents the most promising approach for
improving at least short-term quality of life of gastric cancer pa-
tients [10,11]. With this article we provide the current knowledge,
in terms of feasibility, safety and oncologic efﬁciency of laparo-
scopic treatment for patients with gastric cancer at an early and at
an advanced stage, with an effort to clarify for whom and when the
laparoscopic gastrectomy could be considered a valuable surgical
option.
2. Laparoscopic surgery
The last decade surgery has been revolutionized by a continous
effort toward technical and technological research. All these sci-
entiﬁc attempts are undoubtedly patient-tailored. What is more,
minimally invasive approaches and techniques represent an
exciting solution because they are contributing to improve patient's
quality of life [12]. However, there is the need of high-quality evi-
dence for the enrollment of new technology andminimally invasive
surgical techniques into healthcare system. In this period of eco-
nomic crisis, more than ever, assessing safety, oncologic efﬁciency
and costeeffectiveness analysis are mandatory [13e15].
Our generation is seeing laparoscopic surgery in the multimodal
treatment of solid tumors to expand in clinical practice [14,15].
Nowadays, strong evidences for laparoscopic gastrointestinal can-
cer resections has only emerged for colon cancer. Current evidences
from well conducted randomized controlled trials (RCTs) support
the similar safety and efﬁciency regarding oncological outcomes
and the better quality of life for laparoscopic colectomy, compared
with open colectomy, for patients with stages IeIII colon cancer
[15,16].
3. Laparoscopic surgery for gastric cancer
It is widely known that the ﬁrst early distal gastric cancer series
treated by laparoscopic-assisted gastrectomy (LAG) was described
by Kitano et al., in 1991 [17]. After this report, the procedure has
rapidly achieved popularity in Eastern countries.
It is out of question that laparoscopic gastrectomy represents a
demanding surgical procedure. Experts believe that it is very
difﬁcult to perform a subtotal andmuchmore a total gastrectomy in
a laparoscopic way, especially in patients with high body mass in-
dex (BMI) and cardiovascular or respiratory comorbidities [18,19].
Moreover, it is very difﬁcult to perform laparoscopic lymphade-
nectomy and really experienced hands are needed for this purpose.
As for the alimentary reconstruction after a laparoscopic gastrec-
tomy, the grade of difﬁculty raises from the Billroth I approach to
Billroth II approach and to the gastro-jejunostomy according to the
Roux en Y approach [18,20]. Although these difﬁculties, in order to
additionally reduce the invasiveness, an effort is made by advanced
laparoscopic surgeons, to reduce more the length of the surgical
incisions [21].
Although there are many difﬁculties, most of the researchers
agree that the beneﬁts of the laparoscopic approach are out of
question. Indeed, decreased pain, reduced cosmetic disﬁgurement,shorter length of hospital stay, less postoperative pain and short
term outcomes with better quality of life are some of the expected
beneﬁts for the patients treated via laparoscopic gastrectomy.
Although these beneﬁts, the therapeutic effects in gastric adeno-
carcinoma in terms of surgical safety, oncological efﬁcacy and long
term outcomes still remain unclear [12].
Indeed, laparoscopic approach for gastric cancer patients is
widely routinarialy used by Japanese experienced surgeons.
Differently, laparoscopic gastrectomy is performed only in some
high volume centers in Western countries [22]. However, many
controversies and doubts still exist due to no prospective large
clinical studies to evaluate and describe the rates of overall survival
and the rates of disease free survival of patients with gastric cancer
treated with laparoscopic gastrectomy, especially in Western
countries. On the other hand, more and more controversy exist for
patients treated via total laparoscopic gastrectomy for cancer that
constitutes a very demanding and long lasting surgical procedure
[23].
As for the current guidelines for laparoscopic treatment and
gastric cancer, we have to highlight that there is not exist an
unanimous consensus. The main recommendation is that laparo-
scopic approach should be used only for early gastric cancer and
only by experienced surgeons already highly skilled in gastric
surgery [24,25].
3.1. Current evidence on laparoscopic gastrectomy for cancer
Nowadays, not only the surgical techniques and procedures in
laparoscopic gastrectomy are improving but also the attempt of
adequate lymph node dissection is implementing. Furthermore, the
last two years the East surgeons have dealt with advanced and
demanding procedures including total gastrectomy and extended
lymph node dissection. Recently, some prospective well-conducted
trials have been conducted in Japan and Korea in order to evaluate
the safety and oncological feasibility of laparoscopic gastrectomy
for early or advanced gastric cancer [26e28].
Up to date, there are published several randomized-controlled
trials and metaanalysis that have robustly conﬁrmed that laparo-
scopic gastrectomy is safe, feasible, with efﬁcient oncologic out-
comes and better short-term outcomes than those of open
gastrectomy in patients with early gastric cancer [29,30]. The latest
metaanalysis on this issue was offered by Zhang CD [31]. Pubmed,
Embase, CINAHL, AMED, the Cohrane controlled Trials Register and
the China National Knowledge electronic databases were system-
atically evaluated between 1992 and 2012. Operative time, incision
length, blood loss, number of lymph nodes dissected, time to ﬂatus,
time to ﬁrst oral time assumption, use of analgesics, complications,
length of postoperative stay, recurrence, and mortality were the
examined parameters. An amount of 1665 patients were enrolled
from ﬁve RCTs and 11 case controls studies. Nine hundred patients
with early gastric cancer were treated with laparoscopic gastrec-
tomy, while 746 patients were treated with open gastrectomy. The
results were amazing in favor of laparoscopic gastrectomy for early
gastric cancer in eastern patients. Indeed, laparoscopic gastrectomy
was associated with less trauma (incision length: weighted mean
differences (WMDs)12.91 cm; P< 0.00001), less blood less (WMD
121.04 mL, P < 0.00001), less postoperative pain (number of times
to use analgesics: WMD 1.64; P ¼ 0.001), faster bowel recovery
(time to ﬂatus: WMD 0.62 d; P ¼ 0.0001), fewer complications
(OR 0.57; P ¼ 0.01) and shorter period of postoperative stay (WMD
3.73 d; P ¼ 0.0007). On the other hand, although it was not sta-
tistically signiﬁcant, laparoscopic gastrectomy was associated with
longer operative time and minor number of total dissected lymph
nodes (WMD 3.43 lymph nodes; P ¼ 0.04). No difference in
recurrence rate (OR 0.58; P¼ 0.33) andmortality rate was observed
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[32,33] reported recently the advances of laparoscopic gastrectomy
versus open gastrectomy for patients with early gastric cancer. We
have to highlight that all these data should be carefully validated
and analyzed from a critical point of view also in Western patients
with well conducted prospective trials, but early gastric cancer in
these countries is a rare occasional ﬁnding. Actually, it is known
that most gastric cancer patients in West are diagnosed at an
advanced stage.
As for advanced gastric cancer, a prospective randomized
controlled multicenter trial in order to evaluate the safety and
feasibility of laparoscopic-assisted D2 gastrectomy for advanced
gastric cancer was conducted by Nam BH. et al. and was published
recently [34]. This study enrolled patients with distal gastrectomy
for advanced gastric cancer staged by endoscopy and computed
tomography. Patients were randomized in two groups, either to
laparoscopic distal gastrectomy group or open distal gastrectomy
group. The statistical analyses with power sample size calculation
showed that 102 patients were enough to be included in the two
groups. This trial had as primary end point the non-compliance rate
of D2 dissection. As for the secondary endpoints were the 3-year
disease free survival, surgical and postoperative complications,
hospital stay and rate of D2 dissection evaluated by the intra-
operative video documentation. The main topic for laparoscopic
distal gastrectomy treatment of advanced gastric cancer is the
oncologic safety. Therefore, the non-compliance rate of clearing the
deﬁned N2 area was selected by the authors as the most important
factor for the technical feasibility of the laparoscopic procedure-
approach. This study is underway and the ﬁrst results will offer
promising and exciting evidence of the oncologic feasibility and
safety of laparoscopic-assisted distal gastrectomy for patients with
advanced gastric cancer, which is the main matter of debate today
in Eastern patients [34].
Recently, another metanalysis by Choi Y.Y et al. was published
regarding laparoscopic gastrectomy and its oncologic safety and
efﬁcacy in patients with advanced gastric cancer [35]. Themain end
point of this meta-analysis was to compare laparoscopic gastrec-
tomy and open gastrectomy in terms of long-term outcomes in
patients with advanced gastric cancer. The authors selected studies
from three major databases, PubMed, Embase, and the Cochrane
Central, and the search was performed using keywords related to
advanced gastric cancer and laparoscopic approach until July 31,
2012. Speciﬁcally, ten studies (one RCT and nine retrospective
studies) with a total of 1.816 patients were included in this large
meta-analysis; there were 859 patients were treated with laparo-
scopic gastrectomy for advanced gastric cancer, while 960 patients
were treated via open gastrectomy for the same reason. Nine
studies compared the overall survival rate between laparoscopic
gastrectomy and open gastrectomy for advanced gastric cancer, and
ﬁve studies reported the disease-free survival rates. The authors
concluded that there was no statistical difference in the overall
survival (hazard ratio [HR]: 0.90, 95% conﬁdence interval [CI]:
0.76e1.06, P ¼ 0.22) and in the disease-free survival (HR: 1.03, 95%
CI: 0.76e1.40, P ¼ 0.86) between the two groups of patients for
advanced gastric cancer [35]. In the setting of laparoscopic
approach and its oncologic efﬁcacy for patients with advanced
gastric cancer the most recent metanalysis was conducted by Chen
K. et al. [36]. A carefull search was performed by the authors until
June 2013 to identify all the comparative studies analyzing all
survival rates, recurrence rates, surgical outcomes and surgical
complications. In this metaanalyses a total of 15 trials (two RCTs
and 13 observational studies) with a total of 2.519 patients were
enrolled. Of these patients, 1327 underwent laparoscopic gastrec-
tomy (52.7%) and 1192 underwent open gastrectomy (47.3%). The
researchers reported that laparoscopic gastrectomy wascharacterized by less blood loss [95% CI 174.57 to 103.44, P < 0.001],
earlier time to ﬁrst ﬂatus [95% CI 1.14 to 0.44, P < 0.001], shorter
length of postoperative hospital stay [95% CI 4.13 to 2.09, P < 0.001]
and a decrease in complications [95% CI 0.61 to 0.90, P¼ 0.003]. The
only drawback of laparoscopic gastrectomy compared to open
surgery was the longer operative time involved [95% CI 34.09 to
63.26, P < 0.001]. We have to highlight that the main topic of this
metaanalyses was that no signiﬁcant difference in the number of
total lymph nodes dissected, margin distance, mortality, cancer
recurrence rate and long-term survival rate was observed between
the patients with advanced gastric cancer treatedwith laparoscopic
or open gastrectomy as well (P > 0,05). The most important aspect
to keep in mind is that although a longer operation is needed,
laparoscopic gastrectomy is a safe and oncologically efﬁcient
approach for advanced gastric cancer with a lower complication
rate and improved postoperative length of stay compared to open
gastrectomy. In addition, similar rates in terms of cancer recurrence
and long-term survival was observed for laparoscopic and open
gastrectomy and this highlights the fact that laparoscopic gastrec-
tomy is at least a safe patient-friendly method [37,38].
An original article on the issue of long term results after lapa-
roscopic or open gastrectomy for advanced resectable gastric can-
cer is provided by Kim et al. [39]. In this study, that is the largest
original trial published up to date, ten experienced surgeons from
multiple high-volume centers performing at least 80 gastrectomies
annually were enrolled. The authors report that in total, approxi-
mately 1.500 laparoscopic and 1.500 open gastrectomies over a
period of seven years, were performed for about 3.000 patients. The
authors analyzed 5-year survival rates, morbidity, mortality, and
learning curve for laparoscopic gastrectomy. They report [39,40]
that overall survival, disease-speciﬁc survival, and recurrence-free
survival were no signiﬁcantly different among groups. A better
overall survival rate in the laparoscopic group was observed only
for patients with disease stage IA. There was no signiﬁcant differ-
ence in morbidity or mortality and the mean number of required
learning curve was 42 patients [40]. Interesting issues are raised by
this work, but also more andmore questions. These valuable results
can be reproduced in a safe way for Western patients? It is widely
known that there has been a long matter of debate and is still
ongoing that gastric cancer is ‘different’ in the East and the West.
Various studies report that cancer-related survival is better in Japan
and South Korea, and various reasons have been discussed. Maybe
the explanation key is the different genetic background among East
and West population [41e43].
As for total gastrectomy the criticism and skepticism for lapa-
roscopic gastrectomy is much more exciting. A very recent
metanalysis conducted by Chen K. et al. [44] included nine
comparative observational studies. RCTs were not included in this
metanalysis. A total of 1221 patients were enrolled; 436 patients
were treated with laparoscopic assisted total gastrectomy and 785
patients were treated with open total gastrectomy. The results for
the patients enrolled in the group of laparoscopic total gastrectomy
were characterized by a longer operating time [95% CI:
30.48e84.88; P < 0.001], less blood loss [95% CI: 2.48 e 0.49;
P < 0.001], earlier time to ﬂatus 95%CI: 1.22 -0.30; P < 0.001),
shorter hospital stay (95%CI:3.96 e 1.38, P < 0.001) and a decrease
in medical complications (95%CI:0.19e0.90, P ¼ 0.03). Moreover,
the researchers concluded that the total number of lymph nodes
dissected, mortality, surgical complications, recurrence rate and
long-term survival rate of patients between the open and laparo-
scopic group were similar [45]. From this further representative
metanalysis, we can deduct that despite a longer operation, lapa-
roscopic assisted total gastrectomy can be performed safely in high
volume surgical centers, but are needed well-conducted
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safe conclusions [46e49].
4. Conclusions-future perspectives
In conclusion, we have to highlight the fact that as laparoscopic
experience has been accumulated between surgeons of the eastern
countries, the indications for laparoscopic approaches have
included also more ‘difﬁcult’ and demanding cases with advanced
gastric cancer patients. On the other hand, in Western countries
laparoscopic gastrectomy is in the very beginning stage and when
performed is performed for early gastric cancers. But the early
gastric cancers in Western countries is a very rare event. As it is
known, more than 90% of gastric cancers in the West are diagnosed
at an advanced stage.
The ‘established’ knowledge up to date is that laparoscopic
approach for gastric cancer provides an oncologic validity and
safety for patients with early gastric cancer in experienced hands
and in high volume centers, while for advanced gastric cancer more
prospective trials are needed. The most important aspect to keep in
mind is that laparoscopic gastrectomy constitutes a demanding
operation and for the achievement of valuable long-term results a
real learning curve requires hard training. Given the low quality of
some studies considered in the metaanalyses, the near future with
well-conducted prospective multicenter trias also from Western
countries will tell us if such advanced-demanding laparoscopic
procedures will be translated into real survival beneﬁt for gastric
cancer patients. It seems that new horizons are ahead for laparo-
scopic surgery as the current clinical evidence revealed that the
laparoscopic gastrectomy performed by ‘experienced hands’ is not
inferior to open gastrectomy for early gastric cancer and for
advanced gastric cancer in eastern populations.
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